OptimizeRx Corp
OPRX
查看详细走势图
12.480USD
-0.280-2.19%
收盘 12/26, 16:00（美东）报价延迟15分钟
232.03M总市值
2888.89市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-2.19%
5天
-7.62%
1月
-18.27%
6月
-8.50%
今年开始到现在
+156.79%
1年
+145.19%
查看详细走势图
TradingKey OptimizeRx Corp股票评分
单位: USD 更新时间: 2025-12-26操作建议
OptimizeRx Corp当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在软件与IT服务行业排名99/482位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价24.33。中期看，股价处于下降通道。近一个月，市场表现非常差，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
OptimizeRx Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
7
位分析师
买入
评级
24.333
目标均价
+73.69%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
OptimizeRx Corp亮点
亮点风险
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
业绩高增长
公司营业收入稳步增长，连续3年增长47.52%
业绩增长期
公司处于发展阶段，最新年度总收入92.13M美元
利润高增长
公司净利润处于行业前列，最新年度总收入92.13M美元
估值高估
公司最新PE估值2888.89，处于3年历史高位
机构减仓
最新机构持股13.52M股，环比减少29.35%
PRFDX持仓
明星投资者PRFDX持仓，最新持仓市值1.73K
活跃度增加
近期活跃度增加，过去20天平均换手率0.89
OptimizeRx Corp新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
OptimizeRx Corp简介
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
公司代码OPRX
公司OptimizeRx Corp
CEOSilvestro (Stephen L)
网址https://www.optimizerx.com/
常见问题
OptimizeRx Corp(OPRX)的当前股价是多少？
OptimizeRx Corp(OPRX)的当前股价是 12.480。
OptimizeRx Corp的股票代码是什么？
OptimizeRx Corp的股票代码是OPRX。
OptimizeRx Corp股票的52周最高点是多少？
OptimizeRx Corp股票的52周最高点是22.250。
OptimizeRx Corp股票的52周最低点是多少？
OptimizeRx Corp股票的52周最低点是3.991。
OptimizeRx Corp的市值是多少？
OptimizeRx Corp的市值是232.03M。
OptimizeRx Corp的净利润是多少？
OptimizeRx Corp的净利润为-20.11M。
现在OptimizeRx Corp(OPRX)的股票是买入、持有还是卖出？
根据分析师评级，OptimizeRx Corp(OPRX)的总体评级为买入，目标价格为24.333。
OptimizeRx Corp(OPRX)股票的每股收益（EPS TTM）是多少
OptimizeRx Corp(OPRX)股票的每股收益（EPS TTM）是0.004。
相关品种
